ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 72 | +414.3% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 14 | -97.9% | 0.00% | – |
| Q1 2017 | $6,000 | +50.0% | 662 | +35.7% | 0.00% | – |
| Q4 2016 | $4,000 | – | 488 | +1933.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 24 | -98.0% | 0.00% | – |
| Q2 2016 | $15,000 | +1400.0% | 1,200 | +1521.6% | 0.00% | – |
| Q1 2016 | $1,000 | -66.7% | 74 | -47.5% | 0.00% | – |
| Q4 2015 | $3,000 | -81.2% | 141 | -84.6% | 0.00% | – |
| Q3 2015 | $16,000 | -46.7% | 915 | -31.9% | 0.00% | – |
| Q2 2015 | $30,000 | +500.0% | 1,344 | +650.8% | 0.00% | – |
| Q1 2015 | $5,000 | – | 179 | +1391.7% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 12 | -99.8% | 0.00% | – |
| Q3 2013 | $80,000 | – | 5,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |